Other languages Renovaro Inc.

Equities

RENB

US29350E1047

Delayed Nasdaq Other stock markets 10:14:25 2024-04-29 am EDT			5-day change	1st Jan Change
1.52 ^USD	-0.65%		-29.77%	-52.37%

Apr. 24	Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	MT
Apr. 18	Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	Apr. 24
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	Apr. 18
Renovaro Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14
Renovaro Inc. Announces Board Changes	Feb. 14
Sector Update: Health Care Stocks Gain Late Afternoon	Feb. 14
Sector Update: Health Care	Feb. 14
Renovaro Shares Jump After Response to Short Seller Hindenburg's Report	Feb. 14
Sector Update: Health Care Stocks Decline Late Afternoon	Feb. 13
Renovaro's GEDi Cube Agrees to Acquire 75% Stake in Cyclomics	Feb. 13
Renovaro Shares Tumble Following Report From Short-Seller Hindenburg	Feb. 13
Renovaro Biosciences Inc. completed the acquisition of GEDi Cube Intl Ltd.	Feb. 12
Top Premarket Gainers	Feb. 07
Renovaro Biosciences' Shareholders Approve Share Issuance for Merger Deal With GEDi Cube	Jan. 25
Renovaro Biosciences Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 14
Renovaro Biosciences Inc. Appoints Avram Miller as Board of Directors	23-10-11
Renovaro Biosciences Inc. Appoints Leni Boeren and Ruud Hendriks as Independent Directors	23-10-10
Renovaro Biosciences Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	23-10-02
GEDi Cube und Renovaro Biosciences unterzeichnen endgültige Fusionsvereinbarung	23-09-30
GEDi Cube y Renovaro Biosciences firman un acuerdo definitivo para combinar las empresas	23-09-30
GEDi Cube e Renovaro Biosciences siglano un accordo definitivo per realizzare una business combination	23-09-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Renovaro Inc.

Equities

RENB

US29350E1047

Other languages

Filters